Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue for vascular paralysis in obstructive jaundice
NCT03406676Unknown
- Sponsor
- Southwest Health System
- Start
- Aug 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of methylene blue in obstructive jaundice (2 arms), sponsored by Southwest Health System. Primary endpoint: Peripheral vascular resistance at 6 hours. Status: unknown.
02
Drugs
methylene blue
03
Conditions
obstructive jaundice
Beyond the preview
Go deeper on NCT03406676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03406676.